4 Things to know about PhRMA’s new 50-state poll
PhRMA
MAY 4, 2023
When it comes to health care, Americans are concerned about innovation and affordability.
Thu.May 04, 2023
285 
Biosimilars Now Look Like a Surer Thing After Initial Skepticism
Drug Topics
MAY 4, 2023
The Inflation Reduction Act boosted the Medicare payment for biosimilars from the standard average sales price plus 6% to 8%.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
New resource underscores the importance of small molecule medicines
PhRMA
MAY 4, 2023
A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines play essential roles in the treatment of different diseases and are indispensable in providing patients, caregivers and health care providers with the tools necessary to achieve improved health outcomes.
VMS Frequency Reduced Considerably by Drug Elinzanetant
Drug Topics
MAY 4, 2023
A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A biopharma CEO opens up about executive salaries — and why he wants to change the status quo
PharmaVoice
MAY 4, 2023
With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.
Morning Rx: May 4, 2023
Drug Topics
MAY 4, 2023
Lawmakers take on harm reduction, in-flight medical emergency kits are under review, and a new Alzheimer drug shows promise.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
New Narcolepsy Medication to Be Priced Competitively, Manufacturer Says
Drug Topics
MAY 4, 2023
Despite having a highly differentiated clinical value proposition compared to branded, twice-nightly oxybates, Avadel is pricing Lumryz at $64.67 per gram or around $177,034 annually, which is on par with twice-nightly oxybate products that require chronic, middle-of-the-night awakening.
Navigating workforce challenges amid a turbulent biopharma market
PharmaVoice
MAY 4, 2023
A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.
Horizon taps AI provider Solera Health in effort to offer more customized care to members
Fierce Healthcare
MAY 4, 2023
Horizon taps AI provider Solera Health in effort to offer more customized care to members fdiamond Thu, 05/04/2023 - 14:16
Roche opens new institute to advance research in human model systems
Pharmaceutical Technology
MAY 4, 2023
Roche has opened a new institute to accelerate research and development (R&D) in the area of human model systems such as organoids. Situated in Basel, Switzerland, the newly launched Institute of Human Biology (IHB) will accommodate scientists and bioengineers from academia and the pharmaceutical sector. Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Approves Ivacaftor for Eligible Infants Ages 1 Month and Older With Cystic Fibrosis
Pharmacy Times
MAY 4, 2023
Ivacaftor is now the first and only cystic fibrosis transmembrane conductance regulator modulator approved for this age group.
Sutter Health opens 2023 with $194M gain, 2.3% operating margin
Fierce Healthcare
MAY 4, 2023
Sutter Health opens 2023 with $194M gain, 2.
Provider Recommendation Influences Rate of Pneumococcal Vaccination in High-Risk Patients
Pharmacy Times
MAY 4, 2023
Study sheds light on the importance of the source of vaccine information and other factors that prevent lifesaving influenza or pneumococcal vaccination.
Five takeaways from the new donanemab data
pharmaphorum
MAY 4, 2023
Five takeaways from the new donanemab data Phil.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pneumococcal Vaccination Rates Have Risen in Patients With Rheumatic Diseases
Pharmacy Times
MAY 4, 2023
It is possible that the pandemic had a positive impact on influenza vaccination rates.
Telehealth company Amwell hit with $330M impairment charge as share price declines
Fierce Healthcare
MAY 4, 2023
Telehealth company Amwell hit with $330M impairment charge as share price declines hlandi Thu, 05/04/2023 - 07:40
Study: Women With Breast Cancer in Racially, Ethically Diverse Neighborhoods Have Worse Cancer-Specific Survival Outcomes
Pharmacy Times
MAY 4, 2023
Study examines association between breast cancer survival and neighborhood-level measures such as socioeconomic status.
Drug Store News launches Instagram channel
Drug Store News
MAY 4, 2023
The social media site is another way for the audience to engage with the brand.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Roche launches human model systems institute
pharmaphorum
MAY 4, 2023
Roche launches human model systems institute Phil.
Kroger to feature Tovla Jr. cookware products for kids
Drug Store News
MAY 4, 2023
Tovla Jr. products are available at more than 500 Kroger stores nationwide.
STAT+: Gilead foresees more growth in its HIV drugs
STAT
MAY 4, 2023
Gilead Sciences is famous — or perhaps, notorious — for its cure for hepatitis C. But the pharma giant believes the foundation of its company will continue to be its HIV franchise, particularly the pre-exposure prophylaxis (PrEP) drugs that help prevent the infection. “It’s extraordinary that in this day and age, you still have the incidence of HIV increasing around the world, and even in this country,” CEO Daniel O’Day said Thursday at the STAT Breakthr
Forge Biologics and Labcorp partner for gene therapies development
Pharmaceutical Technology
MAY 4, 2023
Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. Gene therapy clients will gain access to coordinated scientific expertise, drug development services and AAV manufacturing capabilities, advancing the development of new gene therapies.
STAT+: NIH grant recipients often fail to disclose agency support in patent applications
STAT
MAY 4, 2023
The National Institutes of Health may be the largest public funder of biomedical research in the U.S., but its contributions to drug development are not well understood or recognized by most Americans. And a new analysis finds a key reason may be most institutions and researchers that receive NIH support fail to fully or correctly disclose this information when applying for patents.
Moderna warns of severe sales slowdown in Q2, takes $378M charge amid lull in vaccinations
Fierce Pharma
MAY 4, 2023
Moderna warns of severe sales slowdown in Q2, takes $378M charge amid lull in vaccinations aliu Thu, 05/04/2023 - 10:02
STAT+: New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
STAT
MAY 4, 2023
WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage. Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.
One killed, 4 injured in Atlanta medical office mass shooting
Fierce Healthcare
MAY 4, 2023
One killed, 4 injured in Atlanta medical office mass shooting dmuoio Thu, 05/04/2023 - 14:22
STAT+: A new list ranks large pharmaceutical companies by research and development
STAT
MAY 4, 2023
If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. But if you have a medicine you’d like to get to market — and you want to see it generate revenue — you might be better off with Pfizer. That’s the message from the 12th edition of the Pharmaceutical Innovation and Invention Index, produced by the consultancy Idea Pharma, which was released Thursday at the STAT Breakthrough Summit.
What’s the rarest blood type?
The Checkup by Singlecare
MAY 4, 2023
Do you know your blood type? If you do not, you are like most people. If you’re ever in a life-threatening situation requiring a blood transfusion, your blood type will always be checked. That’s because if you’re given an incompatible blood donation, your immune system will attack the donor blood by forming antibodies to destroy the unrecognized “foreign invaders.
Covid and mpox are here to stay, but the WHO’s emergencies may be nearing an end
STAT
MAY 4, 2023
Over the next week or so, the World Health Organization may declare a formal end to two long-running global health emergencies, Covid-19 and the mpox outbreak, after independent expert panels meet to assess whether these health events still merit being called Public Health Emergencies of International Concern. What the panels will recommend, and what WHO Director-General Tedros Adhanom Ghebreyesus will ultimately decide, remains to be seen.
Transforming oncology with antibody therapeutics
European Pharmaceutical Review
MAY 4, 2023
Data announced at the European Lung Cancer Congress (ELCC) earlier this month revealed the long-term efficacy and safety of RYBREVANT ® (amivantamab) in patients with post-platinum EGFR Ex20ins-mutated advanced non-small cell lung cancer (NSCLC). Amivantamab was the first bispecific monoclonal antibody (BsMAb) approved in the EU to treat advanced NSCLC with EGFR exon 20 insertion mutations post chemotherapy.
Opinion: Why a chatbot might seem more empathetic than a human physician
STAT
MAY 4, 2023
An April 28 article in JAMA Internal Medicine , “Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum,” generated a great deal of discussion — much of it horrified. In particular, people are focusing on the study’s conclusions: that “chatbot responses were longer than physician responses, and the study’s health care professional evaluators preferred chatbot-generated responses over p
EMA to review CTIS transparency rules
European Pharmaceutical Review
MAY 4, 2023
The European Medicines Agency (EMA) has opened a public consultation to review the transparency rules for information submitted through the EU Clinical Trials Information System ( CTIS ). Clinical Trials Information System mandatory in EU… The review aims to generate discussion on the best approaches to balance clinical trial transparency with confidentiality requirements.
STAT+: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way
STAT
MAY 4, 2023
In the beginning, Conner Curran ran up the stairs. It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.
Let's personalize your content